LGVN
Longeveron LLC
NASDAQ: LGVN · HEALTHCARE · BIOTECHNOLOGY
$0.85
-1.74% today
Updated 2026-04-30
Market cap
$26.35M
P/E ratio
—
P/S ratio
21.98x
EPS (TTM)
$-1.29
Dividend yield
—
52W range
$0 – $2
Volume
6.9M
Longeveron LLC (LGVN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,479.00%
ROE
-164.70%
ROA
-81.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $2.13M | $-6.34M | 31.88% | -297.95% | -296.84% |
| 2019 | $5.63M | $-3.72M | 32.44% | -67.12% | -66.09% |
| 2020 | $5.63M | $-3.72M | 32.44% | -67.12% | -66.10% |
| 2021 | $1.31M | $-17.05M | 45.18% | -1,336.60% | -1,305.13% |
| 2022 | $1.22M | $-18.84M | 40.67% | -1,476.51% | -1,541.33% |
| 2023 | $709000.00 | $-21.41M | 31.17% | -2,966.01% | -3,020.17% |
| 2024 | $2.39M | $-15.97M | 78.76% | -690.72% | -667.77% |
| 2025 | $1.20M | $-22.70M | 66.97% | -1,942.20% | -1,893.58% |